George Demetri - Net Worth and Insider Trading
George Demetri Net Worth
The estimated net worth of George Demetri is at least $897,560 dollars as of 2024-05-13. George Demetri is the Director of Blueprint Medicines Corp and owns about 8,412 shares of Blueprint Medicines Corp (BPMC) stock worth over $897,560. Details can be seen in George Demetri's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that George Demetri has not made any transactions after 2022-03-17 and currently still holds the listed stock(s).
Transaction Summary of George Demetri
George Demetri Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, George Demetri owns 3 companies in total, including Blueprint Medicines Corp (BPMC) , Translate Bio Inc (TBIO) , and Merrimack Pharmaceuticals Inc (MACK) .
Click here to see the complete history of George Demetri’s form 4 insider trades.
Insider Ownership Summary of George Demetri
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BPMC | Blueprint Medicines Corp | 2022-03-17 | director |
| TBIO | Translate Bio Inc | 2020-06-16 | director |
| MACK | Merrimack Pharmaceuticals Inc | 2017-11-29 | director |
George Demetri Latest Holdings Summary
George Demetri currently owns a total of 1 stock. George Demetri owns 8,412 shares of Blueprint Medicines Corp (BPMC) as of March 17, 2022, with a value of $897,560.
Latest Holdings of George Demetri
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BPMC | Blueprint Medicines Corp | 2022-03-17 | 8,412 | 106.70 | 897,560 |
Holding Weightings of George Demetri
George Demetri Form 4 Trading Tracker
According to the SEC Form 4 filings, George Demetri has made a total of 8 transactions in Blueprint Medicines Corp (BPMC) over the past 5 years, including 1 buys and 7 sells. The most-recent trade in Blueprint Medicines Corp is the sale of 10 shares on March 17, 2022, which brought George Demetri around $586.
Insider Trading History of George Demetri
- 1
George Demetri Trading Performance
GuruFocus tracks the stock performance after each of George Demetri's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by George Demetri is 19.42%. GuruFocus also compares George Demetri's trading performance to market benchmark return within the same time period. The performance of stocks bought by George Demetri within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how George Demetri's insider trading performs compared to the benchmark.
Performance of George Demetri
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 14.35 | | | | | |
| Relative Return to S&P 500(%) | 12.09 | | | | | |
George Demetri Ownership Network
George Demetri Owned Company Details
What does Blueprint Medicines Corp do?
Who are the key executives at Blueprint Medicines Corp?
George Demetri is the director of Blueprint Medicines Corp. Other key executives at Blueprint Medicines Corp include Principal FAO Michael Landsittel , Principal Accounting Officer Ariel Hurley , and director & CEO & President Jeffrey W. Albers .
Blueprint Medicines Corp (BPMC) Insider Trades Summary
Over the past 18 months, George Demetri made no insider transaction in Blueprint Medicines Corp (BPMC). Other recent insider transactions involving Blueprint Medicines Corp (BPMC) include a net sale of 175,899 shares made by Jeffrey W. Albers , a net sale of 11,217 shares made by Christopher K. Murray , and a net sale of 36,744 shares made by Michael Landsittel .
In summary, during the past 3 months, insiders sold 130,368 shares of Blueprint Medicines Corp (BPMC) in total and bought 0 shares, with a net sale of 130,368 shares. During the past 18 months, 312,641 shares of Blueprint Medicines Corp (BPMC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 312,641 shares.
Blueprint Medicines Corp (BPMC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Blueprint Medicines Corp Insider Transactions
George Demetri Mailing Address
Above is the net worth, insider trading, and ownership report for George Demetri. You might contact George Demetri via mailing address: Blueprint Medicines Corp., 215 First Street, Suite 340/350, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
